Nektar

3 Biotech Stocks That Soared This Week
Motley Fool
Sun, 11/12/17 - 10:32 am
biotech
Nektar
earnings
SAGE Therapeutics
brexanolone
postpartum depression
Valeant Pharmaceuticals
Eli Lilly offers $400M-plus deal to bag an early-stage autoimmune drug from Nektar
Endpoints
Mon, 07/24/17 - 10:46 am
Eli Lilly
autoimmune disease
NKTR-358
Nektar
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
EMA
Europe
Pfizer
Bavencio
Novartis
Rydapt
Lexicon Pharmaceuticals
Xermelo
Vanda
Fanaptum
Nektar
Onzeald
Daiichi Sankyo
Nektar’s pitch on early cancer drug OK runs into a regulatory brick wall
Endpoints
Sat, 07/22/17 - 09:57 am
Nektar
regulatory
Onzeald
Europe
Daiichi Sankyo
[video]Can Drugmakers Cure the Opioid Crisis?
Motley Fool
Tue, 04/18/17 - 09:45 am
opioids
opioid abuse
opioid crisis
Pacira
Cara Therapeutics
Nektar
Flexion
Nektar's opioid painkiller succeeds in key late-stage study
Yahoo/Reuters
Mon, 03/20/17 - 09:42 am
Nektar
painkillers
opioids
clinical trials
Bristol-Myers to test Opdivo with Nektar drug for several cancers
Yahoo/Reuters
Tue, 09/27/16 - 10:47 am
Bristol-Myers Squibb
Opdivo
Nektar
NKTR-214
PD-1 inhibitors
cancer
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
24/7 Wall St
Sat, 04/18/15 - 12:16 pm
Cerus
Nektar
Idera Pharmaceuticals
BioDelivery Sciences
Biocryst
Breast cancer drug, key to Nektar growth plans, fails clinical trial
Bizjournals.com
Tue, 03/17/15 - 07:23 pm
Nektar
NKTR-102
breast cancer
As PhIII data looms, Nektar sets the stage for a big expansion
Fierce Biotech
Thu, 01/22/15 - 02:42 pm
Nektar
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
TheStreet.com
Tue, 09/16/14 - 01:41 pm
AstraZeneca
Movantik
FDA
opioid-induced constipation
Nektar
FDA approves AstraZeneca, Nektar constipation drug
Yahoo/Reuters
Tue, 09/16/14 - 11:55 am
FDA
AstraZeneca
Nektar
Movantik
opioid-induced constipation
September Biotech Calendar
TheStreet.com
Tue, 08/26/14 - 10:08 am
Keryx
Orexigen
AstraZeneca
Nektar
Salix
Alimera
Amarin
Merck
EXACT Sciences
NPS Pharmaceuticals
U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
Mon, 06/9/14 - 11:04 am
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, at 50th ASCO Meeting
Yahoo/PR NewsWire
Sun, 06/1/14 - 11:51 am
NKTR-214
Nektar
breast cancer
Nektar reports positive preclinical data for two oncology programs
The Fly on the Wall
Wed, 04/9/14 - 11:50 am
Nektar
NKTR-102
NKTR-214
breast cancer
Nektar Rises on FDA Notification
Yahoo/Zacks.com
Thu, 03/20/14 - 09:07 am
FDA
Nektar
AstraZeneca
Naloxegol
opioid-induced constipation
3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
Motley Fool
Mon, 02/24/14 - 10:10 am
Nektar
Omeros
Spectrum Pharmaceuticals
Nektar Momentum Continues To Grow
Seeking Alpha
Wed, 01/22/14 - 03:46 pm
Nektar
Naloxegol
Nektar presents data from Phase l study of etirinotecan pegol
Yahoo/Fly on the Wall
Mon, 01/20/14 - 11:09 am
Nektar
etirinotecan pegol
NKTR-102
advanced cancer

Pages